Vaxxa
0.56 SEK
-1.06 %
Less than 1K followers
VAXXA
Spotlight Stock Market
Software
Technology
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vaxxa
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 21.4 | 16.8 | 77.0 | 12.3 | 18.9 | 21.1 | 22.9 | 75.2 |
| EBITDA | 0.6 | -0.5 | 2.4 | -0.1 | -1.0 | 0.0 | -0.8 | -1.9 |
| EBIT | -0.0 | -0.7 | 0.3 | -0.7 | -1.7 | -0.6 | -1.2 | -4.2 |
| EBIT-% | -0.1 % | -3.9 % | 0.4 % | -5.8 % | -8.8 % | -3.0 % | -5.1 % | -5.6 % |
| Profit before taxes | 0.0 | -0.6 | 0.4 | -0.7 | -1.6 | -0.5 | -1.4 | -4.1 |
| Net income | 0.0 | -0.6 | 0.4 | -0.7 | -1.6 | -0.5 | -1.4 | -4.1 |